Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate

BACKGROUND: Polymyxin B and E (colistin) have been pivotal in the treatment of XDR Gram-negative bacterial infections; however, resistance has emerged. A structurally related lipopeptide, octapeptin C4, has shown significant potency against XDR bacteria, including polymyxin-resistant strains, but it...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Antimicrob Chemother
Päätekijät: Pitt, Miranda E, Cao, Minh Duc, Butler, Mark S, Ramu, Soumya, Ganesamoorthy, Devika, Blaskovich, Mark A T, Coin, Lachlan J M, Cooper, Matthew A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2019
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6376851/
https://ncbi.nlm.nih.gov/pubmed/30445429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dky458
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia